Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 21:10:6.
doi: 10.1186/s13601-020-0311-6. eCollection 2020.

Study of atopic multimorbidity in subjects with rhinitis using multiplex allergen component analysis

Affiliations

Study of atopic multimorbidity in subjects with rhinitis using multiplex allergen component analysis

Viiu Blöndal et al. Clin Transl Allergy. .

Abstract

Background: Rhinitis is a common problem within the population. Many subjects with rhinitis also have atopic multimorbidity, such as asthma and eczema. The purpose of this investigation was to compare subjects with only rhinitis to those that have rhinitis, asthma and/or eczema in relation to immunoglobulin E (IgE) sensitization, inflammatory markers, family history, lung function and body mass index (BMI).

Methods: A total of 216 adult subjects with rhinitis from the European Community Respiratory Health Survey II were investigated with multiplex component allergen analysis (103 allergen components), total IgE, C-reactive protein, eosinophilic cationic protein, fractional exhaled nitric oxide and spirometry. Rhinitis, eczema, asthma and parental allergy were questionnaire-assessed.

Results: Of the 216 participants with rhinitis, 89 also had asthma and/or eczema. Participants with rhinitis that also had asthma or eczema were more likely to be IgE-sensitized (3.44, odds ratio, OR: 95% CI 1.62-7.30, adjusted for sex, age, mother's allergy, total IgE and forced expiratory volume (FEV1)). The number of IgE-positive components was independently associated with atopic multimorbidity (1.11, OR: 95% Cl 1.01-1.21) adjusted for sex, age, mother's allergy, total IgE and FEV1. When analysing different types of sensitization, the strongest association with atopic multimorbidity was found in participants that were IgE-sensitized both to perennial and seasonal allergens (4.50, OR: 95% CI 1.61-12.5). Maternal allergy (2.75, OR: 95% CI 1.15-4.46), high total IgE (2.38, OR: 95% CI 1.21-4.67) and lower FEV1 (0.73, OR: 95% CI 0.58-0.93) were also independently associated with atopic multimorbidity, while no association was found with any of the other inflammatory markers.

Conclusion: IgE polysensitization, to perennial and seasonal allergens, and levels of total IgE seem to be the main determinants of atopic multimorbidity in subjects with rhinitis. This indicates that disease-modifying treatment that targets IgE sensitization may be of value when decreasing the risk of developing atopic multimorbidity.

Keywords: Asthma; Atopic multimorbidity; Eczema; Multiplex component analysis; Rhinitis.

PubMed Disclaimer

Conflict of interest statement

Competing interestsMagnus P. Borres is affiliated with Thermofisher Scientific (Sweden) that also provided financial support for this study. No other author has reported any conflict of interest.

Figures

Fig. 1
Fig. 1
Flow chart for the inclusion of subjects
Fig. 2
Fig. 2
Asthma and eczema in participants with rhinitis. *The distribution of rhinitis subjects (n = 216) and subjects with eczema (n = 39) within different subgroups
Fig. 3
Fig. 3
Sensitisation to allergen components in the ISAC panel. *The column on the left represents subjects with only rhinitis and the column on the right subjects with rhinitis that also have eczema, asthma or both. The darker the colour (yellow, orange, red), the higher the test result
Fig. 4
Fig. 4
Association between the number of IgE-positive allergen components and having rhinitis with asthma/eczema. *median and interquartile range

Similar articles

  • Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GA2 LEN study.
    Blöndal V, Malinovschi A, Sundbom F, James A, Middelveld R, Franklin KA, Lundbäck B, Janson C. Blöndal V, et al. Clin Exp Allergy. 2021 Feb;51(2):262-272. doi: 10.1111/cea.13759. Epub 2020 Oct 25. Clin Exp Allergy. 2021. PMID: 33053244 Free PMC article.
  • IgE antibodies in relation to prevalence and multimorbidity of eczema, asthma, and rhinitis from birth to adolescence.
    Ballardini N, Bergström A, Wahlgren CF, van Hage M, Hallner E, Kull I, Melén E, Antó JM, Bousquet J, Wickman M. Ballardini N, et al. Allergy. 2016 Mar;71(3):342-9. doi: 10.1111/all.12798. Epub 2015 Dec 22. Allergy. 2016. PMID: 26505741
  • Atopic disease and exhaled nitric oxide in an unselected population of young adults.
    van Asch CJ, Balemans WA, Rovers MM, Schilder AG, van der Ent CK. van Asch CJ, et al. Ann Allergy Asthma Immunol. 2008 Jan;100(1):59-65. doi: 10.1016/S1081-1206(10)60406-1. Ann Allergy Asthma Immunol. 2008. PMID: 18254484
  • Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes.
    Anto JM, Bousquet J, Akdis M, Auffray C, Keil T, Momas I, Postma DS, Valenta R, Wickman M, Cambon-Thomsen A, Haahtela T, Lambrecht BN, Lodrup Carlsen KC, Koppelman GH, Sunyer J, Zuberbier T, Annesi-Maesano I, Arno A, Bindslev-Jensen C, De Carlo G, Forastiere F, Heinrich J, Kowalski ML, Maier D, Melén E, Smit HA, Standl M, Wright J, Asarnoj A, Benet M, Ballardini N, Garcia-Aymerich J, Gehring U, Guerra S, Hohmann C, Kull I, Lupinek C, Pinart M, Skrindo I, Westman M, Smagghe D, Akdis C, Andersson N, Bachert C, Ballereau S, Ballester F, Basagana X, Bedbrook A, Bergstrom A, von Berg A, Brunekreef B, Burte E, Carlsen KH, Chatzi L, Coquet JM, Curin M, Demoly P, Eller E, Fantini MP, von Hertzen L, Hovland V, Jacquemin B, Just J, Keller T, Kiss R, Kogevinas M, Koletzko S, Lau S, Lehmann I, Lemonnier N, Mäkelä M, Mestres J, Mowinckel P, Nadif R, Nawijn MC, Pellet J, Pin I, Porta D, Rancière F, Rial-Sebbag E, Saeys Y, Schuijs MJ, Siroux V, Tischer CG, Torrent M, Varraso R, Wenzel K, Xu CJ. Anto JM, et al. J Allergy Clin Immunol. 2017 Feb;139(2):388-399. doi: 10.1016/j.jaci.2016.12.940. J Allergy Clin Immunol. 2017. PMID: 28183433 Review.
  • [Allergic rhinitis and bronchial hyperreactivity].
    Valdesoiro L, Bosque M, Marco MT, Asensio O, Antón J, Larramona H. Valdesoiro L, et al. Allergol Immunopathol (Madr). 2004 Nov-Dec;32(6):340-3. doi: 10.1016/s0301-0546(04)79266-6. Allergol Immunopathol (Madr). 2004. PMID: 15617661 Review. Spanish.

Cited by

  • Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.
    Sousa-Pinto B, Anto A, Berger M, Dramburg S, Pfaar O, Klimek L, Jutel M, Czarlewski W, Bedbrook A, Valiulis A, Agache I, Amaral R, Ansotegui IJ, Bastl K, Berger U, Bergmann KC, Bosnic-Anticevich S, Braido F, Brussino L, Cardona V, Casale T, Canonica GW, Cecchi L, Charpin D, Chivato T, Chu DK, Cingi C, Costa EM, Cruz AA, Devillier P, Durham SR, Ebisawa M, Fiocchi A, Fokkens WJ, Gemicioğlu B, Gotua M, Guzmán MA, Haahtela T, Ivancevich JC, Kuna P, Kaidashev I, Khaitov M, Kvedariene V, Larenas-Linnemann DE, Lipworth B, Laune D, Matricardi PM, Morais-Almeida M, Mullol J, Naclerio R, Neffen H, Nekam K, Niedoszytko M, Okamoto Y, Papadopoulos NG, Park HS, Passalacqua G, Patella V, Pelosi S, Pham-Thi N, Popov TA, Regateiro FS, Reitsma S, Rodriguez-Gonzales M, Rosario N, Rouadi PW, Samolinski B, Sá-Sousa A, Sastre J, Sheikh A, Ulrik CS, Taborda-Barata L, Todo-Bom A, Tomazic PV, Toppila-Salmi S, Tripodi S, Tsiligianni I, Valovirta E, Ventura MT, Valero AA, Vieira RJ, Wallace D, Waserman S, Williams S, Yorgancioglu A, Zhang L, Zidarn M, Zuberbier J, Olze H, Antó JM, Zuberbier T, Fonseca JA, Bousquet J. Sousa-Pinto B, et al. Clin Transl Allergy. 2022 Nov;12(11):e12208. doi: 10.1002/clt2.12208. Clin Transl Allergy. 2022. PMID: 36434742 Free PMC article.
  • One march, many paths: Insights into allergic march trajectories.
    Gabryszewski SJ, Hill DA. Gabryszewski SJ, et al. Ann Allergy Asthma Immunol. 2021 Sep;127(3):293-300. doi: 10.1016/j.anai.2021.04.036. Epub 2021 May 7. Ann Allergy Asthma Immunol. 2021. PMID: 33971364 Free PMC article. Review.
  • Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps.
    Sousa-Pinto B, Pfaar O, Bousquet J. Sousa-Pinto B, et al. Allergol Select. 2023 Mar 1;7:47-56. doi: 10.5414/ALX02343E. eCollection 2023. Allergol Select. 2023. PMID: 36925994 Free PMC article. Review.
  • Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GA2 LEN study.
    Blöndal V, Malinovschi A, Sundbom F, James A, Middelveld R, Franklin KA, Lundbäck B, Janson C. Blöndal V, et al. Clin Exp Allergy. 2021 Feb;51(2):262-272. doi: 10.1111/cea.13759. Epub 2020 Oct 25. Clin Exp Allergy. 2021. PMID: 33053244 Free PMC article.
  • Clinical relevance of cluster analysis in phenotyping allergic rhinitis in the paediatric population of the Kuyavian-Pomeranian voivodeship, Poland.
    Kowalczyk A, Krogulska A. Kowalczyk A, et al. Postepy Dermatol Alergol. 2024 Feb;41(1):56-65. doi: 10.5114/ada.2023.135676. Epub 2024 Feb 28. Postepy Dermatol Alergol. 2024. PMID: 38533360 Free PMC article.

References

    1. Pols DH, Wartna JB, van Alphen EI, Moed H, Rasenberg N, Bindels PJ, et al. Interrelationships between atopic disorders in children: a meta-analysis based on ISAAC questionnaires. PLoS ONE. 2015;10(7):e0131869. doi: 10.1371/journal.pone.0131869. - DOI - PMC - PubMed
    1. Leynaert B, Neukirch F, Demoly P, Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol. 2000;106(5 Suppl):S201–S205. doi: 10.1067/mai.2000.110151. - DOI - PubMed
    1. Greisner WA, 3rd, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc. 1998;19(4):185–188. doi: 10.2500/108854198778557836. - DOI - PubMed
    1. Aronsson D, Tufvesson E, Ankerst J, Bjermer L. Allergic rhinitis with hyper-responsiveness differ from asthma in degree of peripheral obstruction during metacholine challenge test. Clin Physiol Funct Imaging. 2008;28(2):81–85. doi: 10.1111/j.1475-097X.2007.00772.x. - DOI - PubMed
    1. Aronsson D, Tufvesson E, Bjermer L. Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide. Clin Exp Allergy. 2005;35(11):1457–1461. doi: 10.1111/j.1365-2222.2005.02363.x. - DOI - PubMed